Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: Randomised controlled trial

BMJ (Online)

Volumn 345, Issue 7870, 2012, Pages

  Hollands, Gareth J ^a   Whitwell, Sophia C L ^a   Parker, Richard A ^b   Prescott, Natalie J ^c   Forbes, Alastair ^d   Sanderson, Jeremy ^e   Mathew, Christopher G ^c   Lewis, Cathryn M ^c   Watts, Sally ^f   Sutton, Stephen ^b   Armstrong, David ^a   Kinmonth, Ann Louise ^b   Prevost, A Toby ^a   Marteau, Theresa M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; DNA;

ADULT; ARTICLE; AUDIO RECORDING; BEHAVIOR CHANGE; CIGARETTE SMOKING; CLUSTER ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DNA DETERMINATION; FAMILY HISTORY; FEEDBACK SYSTEM; FEMALE; GENE; GENE MUTATION; GENOTYPE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MOTIVATION; NOD2 GENE; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELATIVE; RISK ASSESSMENT; RISK REDUCTION; SMOKING CESSATION; TELEPHONE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FAMILY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; METHODOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PSYCHOLOGICAL ASPECT; SMOKING; UNITED KINGDOM;

ADULT; ATTITUDE TO HEALTH; CROHN DISEASE; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NOD2 SIGNALING ADAPTOR PROTEIN; OUTCOME ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; SMOKING; SMOKING CESSATION;

EID: 84865208699     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e4708     Document Type: Article

References (41)

1. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature 2003;422:835-47.
2. Gramling R, Nash J, Siren K, Culpepper L. Predictive genetics in primary care: expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk. Genet Med 2003;5:172-5.
3. Collins F. Has the revolution arrived? Nature 2010;464:674-5.
4. Chen S, Chaiken S. The heuristic-systematic model in its broader context. In: Chaiken S, Trope Y, eds. Dual process theories in social psychology Guildford Press, 1999:73-96.
5. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54.
6. Brant SR, Wang M-H, Rawsthorne P, Sargent M, Datta LW, Nouvet F, et al. A population-based case-control study of card15 and other risk factors in Crohn's disease and ulcerative colitis. Am J Gastroenterol 2007;102:313-23.
7. Forbes A. Inflammatory bowel disease: a clinician's guide. 2nd ed. Arnold, 2001.
8. Lewis CM, Whitwell SCL, Forbes A, Sanderson J, Mathew CG, Marteau TM. Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet 2007;44:689-94.
9. Fanshawe TR, Prevost AT, Roberts JS, Green RC, Armstrong D, Marteau TM. Explaining behaviour change after genetic testing: the problem of collinearity between test and risk estimates. Genet Test 2008;12:381-6.
10. Marteau TM, Roberts S, LaRusse S, Green RC. Predictive genetic testing for Alzheimer's disease: impact upon risk perception. Risk Anal 2005;25:397-404.
11. Reid EP, Forbes A, Sanderson J, Mathew CG, Lewis C, Marteau TM. Recruiting first-degree relatives for prevention research: a comparison of clinician and proband-led methods of contact in Crohn's disease. Eur J Hum Genet 2006;14:1263-8.
12. West R, McEwen A, Bolling K, Owen L. Smoking cessation and smoking patterns in the general population: a 1-year follow-up. Addiction 2001;96:891-902.
13. Balmford J, Borland R, Burney S. The influence of having a quit date on prediction of smoking cessation outcome. Health Educ Res 2010;25:698-706.
14. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299-303.
15. Whitwell S, Mathew C, Lewis C, Forbes A, Watts S, Sanderson J, et al. Trial protocol: communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking. BMC Public Health 2011;11:44.
16. Donner A, Birkett N, Buck C. Randomisation by cluster. Sample size requirements and analysis. Am J Epidemiol 1981;114:906-14.
17. Mathew C. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008;9:9-14.
18. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 2010;(10):CD007275.
19. Wright AJ, Takeichi C, Whitwell SCL, Hankins M, Marteau TM. The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study. Clin Genet 2008;73:306-14.
20. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2006;(3):CD002850.
21. Fidler J, Shahab L, West O, Jarvis M, McEwen A, Stapleton J, et al. 'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health 2011;11:479.
22. West R. Smoking in England. 2012. www.smokinginengland.info/.
23. Department of Health. NHS stop smoking services. 2012. http://smokefree.nhs.uk/.
24. Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. BMJ 2011;343:d6500.
25. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011;364:524-34.
26. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL Study. Alzheimer Dis Assoc Disord 2008;22:94-7.
27. Evans JP, Meslin EM, Marteau TM, Caulfield T. Deflating the genomic bubble. Science 2011;331:861-2.
28. Bates BR, Templeton A, Achter PJ, Harris TM, Condit CM. What does "A gene for heart disease" mean? A focus group study of public understandings of genetic risk factors: Wiley Subscription Services, 2003:156-61.
29. Shiloh S, Rashuk-Rosenthal D, Benyamini Y. Illness causal attributions: an exploratory study of their structure and associations with other illness cognitions and perceptions of control. J Behav Med 2002;25:373-94.
30. Collins R, Wright A, Marteau T. Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review. Genet Med 2011;13:273-7.
31. Meiser B, Dunn S, Dixon J, Powell LW. Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: a prospective study. J Genet Couns 2005;14:453-63.
32. Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998;9:731-8.
33. Cameron LD, Sherman KA, Marteau TM, Brown PM. Impact of genetic risk information and type of disease on perceived risk, anticipated affect and expected consequences of genetic tests. Health Psychol 2009;28:307-16.
34. Floyd DL, Prentice-Dunn S, Rogers RW. A meta-analysis of research on protection motivation theory. J Appl Soc Psychol 2000;30:407-29.
35. Milne S, Sheeran P, Orbell S. Prediction and intervention in health-related behavior: a meta-analytic review of protection motivation theory. J Appl Soc Psychol 2000;30:106-43.
36. Audrain J, Boyd N, Roth J, Main D, Caporaso N, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav 1997;22:741-51.
37. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J. Psychological and behavioural impact of genetic testing smokers for lung cancer risk - a phase II exploratory trial. J Health Psychol 2008;13:481-94.
38. Hishida A, Terazawa T, Mamiya T, Ito H, Matsuo K, Tajima K, et al. Efficacy of genotype notification to Japanese smokers on smoking cessation - an intervention study at workplace. Cancer Epidemiol 2010;34:96-100.
39. Department of Health. Healthy lives, healthy people: a tobacco control plan for England. Department of Health, 2011. www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-124917.
40. National Preventative Health Taskforce. Taking preventative action - a response to Australia: the healthiest country by 2020. Australian Government, 2010. www.preventativehealth.org.au/internet/preventativehealth/publishing.nsf/ Content/taking-preventative-action.
41. World Health Organization. WHO framework convention on tobacco control. WHO, 2003. www.who.int/fctc/text-download/en/index.html.